Free Republic 3rd Quarter Fundraising Target: $88,000 Receipts & Pledges to-date: $45,501
51%  
Woo hoo!! And we're now over 51%!! Thank you all very much!! God bless.

Keyword: pharma

Brevity: Headers | « Text »
  • Jail Them All (Pharmaceutical Fraud)

    07/20/2017 5:44:40 AM PDT · by Wolfie · 85 replies
    Market Ticker ^ | July 20, 2017 | Karl Denninger
    Jail Them All There is no greater scam in the world today than the blatant and outrageous lies told to everyone from school age onward over the last 40+ years when it comes to diet, exercise, health and various risk factors associated with same. The root of the scam goes back even further, but it really became evident with the so-called "food pyramid" which emphasized refined starches (breads and "white vegetables") and claimed that fats were bad for you and should be limited. Then, the scam evolved. Only saturated fats were bad, so it was claimed. The rest weren't so...
  • Dangerously Addictive Painkiller Patients Who Shouldn’t Have Received It, Says Whistleblower: SUBSY

    06/05/2017 5:11:43 AM PDT · by GailA · 37 replies
    NBCnews ^ | 5/5/17 | Corky Siemaszko
    This DRUG is being used OFF LABEL and KILLS, fueling the FAKE Opioid Crisis. PIG PHARMA pushed. It's called Subsys and it's a painkiller 100 times more powerful than morphine that was approved by the FDA for cancer patients whose agony can't be relieved by other narcotics alone.
  • PINKERTON: A New Vision for Big Pharma and for the American Patient in the Trump Era

    02/22/2017 4:47:54 AM PST · by davikkm · 13 replies
    breitbart ^ | JAMES P. PINKERTON
    First of Four Parts… The Pharma Companies In the Crosshairs During last year’s presidential campaign, candidate Donald Trump said that if elected, he would save the federal government billions by forcing the pharmaceutical companies to negotiate—that is, lower—their prices. On January 11, 2017, President-elect Trump said that the pharma companies were “getting away with murder” in their pricing, and reiterated his demand for new competition policies aimed at bringing down costs. On January 31, President Trump met face-to-face with top executives and offered a more nuanced exposition of his thinking. First, he reiterated his oft-expressed point about the value of...
  • Sharp Rise Reported in Older Americans’ Use of Multiple Psychiatric Drugs

    02/13/2017 10:12:01 AM PST · by MarvinStinson · 51 replies
    NY TIMES ^ | FEB. 13, 2017 | BENEDICT CAREYFEB.
    <p>The number of retirement-age Americans taking at least three psychiatric drugs more than doubled between 2004 and 2013, even though almost half of them had no mental health diagnosis on record, researchers reported on Monday.</p> <p>The new analysis, based on data from doctors’ office visits, suggests that inappropriate prescribing to older people is more common than previously thought. Office visits are a close, if not exact, estimate of underlying patient numbers. The paper appears in the journal JAMA Internal Medicine.</p>
  • Trump opens can of worms with blast at drugmakers

    01/13/2017 6:19:27 AM PST · by GIdget2004 · 72 replies
    The Hill Extra ^ | 01/13/2017 | RACHEL ROUBEIN AND SARAH CHACKO
    President-elect Donald Trump reopened an awkward division over high drug prices with fellow Republicans during his first press briefing this week -- putting lawmakers on defense on an issue they've tried to tamp down. GOP lawmakers reacted in a way they've become accustomed to over the past year: Sorry, but we haven't seen his comments. Yet, Trump's call to "create new bidding procedures for the drug industry" puts Republicans in a tough spot, since it's a measure they traditionally oppose and Democrats historically support. "We can agree to disagree at times," Rep. Chris Collins (R-N.Y.), a key Trump ally in...
  • Big pharma is spending millions to fight limits on opioids like OxyContin, Vicodin and fentanyl

    09/27/2016 4:28:52 AM PDT · by Wolfie · 93 replies
    Vice News ^ | Sept. 18, 2016
    Big pharma is spending millions to fight limits on opioids like OxyContin, Vicodin and fentanyl The pharmaceutical industry has spent more than $880 million over the past decade to fight laws that would limit the availability of powerful opiods such as OxyContin, Vicodin and fentanyl in the United States, according to an investigation by the Associated Press and the Center for Public Integrity published Sunday. Often, these lobbying expenditures are funneled through groups like the American Cancer Society Cancer Action Network and other advocacy groups that represent the interests of patients with terminal cancer or chronic pain, whose conditions can...
  • Here's Everything We Know About The 'Secret Serum' Used To Treat An American With Ebola

    08/04/2014 1:08:30 PM PDT · by blam · 26 replies
    BI ^ | 8-4-2014 | Kevin Loria
    Kevin LoriaAugust. 4, 2014 Both of the Ebola-infected U.S. citizens in Liberia received a rare dose of what news reports called a "secret serum" to treat the virus before being transported to Emory University Hospital in Atlanta, according to a CNN report. And while some people do fight off the disease on their own, in the case of the two Americans, that experimental serum may have saved their lives. As Dr. Kent Brantly and missionary Nancy Writebol waited in a Liberian hospital, someone from the National Institutes of Health reached out to Samaritan's Purse, one of the two North Carolina-based...
  • Barry & Hillary—The Affirmative-Action Presidents

    08/04/2014 7:10:47 AM PDT · by CharlesOConnell
    The Washington Post ^ | 7/31/2014 | Sebastian Payne and Sean Sullivan
    “You’re likable enough, Hillary.” … Barack Obama made that remark in a televised debate ahead of the 2008 New Hampshire primaries. Back then, "more of the public preferred Obama over rival Sen. Hillary Clinton." [Polls, of course, aren't intended to INFLUENCE public opinion, they only REFLECT "Democratic" popular opinion. Psst! Anybody want to buy a bridge?] Read More…
  • Big Insurance was supposed to be "punished" by Obamacare; Big Insurance was behind it all the time

    07/24/2014 4:18:12 PM PDT · by CharlesOConnell · 17 replies
    American Chesterton Society Blog ^ | 2-20-2012 | Dale Ahlquist
    G.K. Chesterton’s Prophetic Look at National Health Care Dale Ahlquist | 2-20-2012 | American Chesterton Society Blogweb.archive.org/web/20130811135205/http://www.chesterton.org/2012/02/a-prophetic-look-at-national-health-care-2/G.K. Chesterton considered himself a member of the Liberal Party until 1912. As he would later say, he did not leave the Liberal Party. It left him. He believed in something called liberty, the idea that people should be able to make most decisions for themselves, especially the most basic and most important decisions, and not have such decisions made for them by anyone else, especially by the government. He believed, as a liberal, that the State’s role was to preserve liberty, not take...
  • Masters Pharmaceutical Responds To FDA On Ohio Drug Seizures

    05/25/2014 7:19:26 PM PDT · by mgist · 11 replies
    pharmaceutical O nline ^ | 5/23/14 | Root
    Masters Pharmaceutical Responds To FDA On Ohio Drug Seizures By Cyndi Root Masters Pharmaceutical issued a press release disputing the Food and Drug Administration’s (FDA) position on the raid at Master’s subsidiary RXTPL. The FDA and U.S. Marshalls went to RXTPL’s logistics facility in Fairfield, Ohio on Thursday, May 15, 2014. The government had a search warrant based on a November 2013 inspection at Ascend Laboratories, which showed the use of unapproved drugs. Masters says that RXTPL cooperated with the government in quarantining the drugs at the facility. However, Masters takes issue with the FDA press release that states that...
  • ObamaCare’s Crony Capitalism: Worse than We Thought

    11/11/2013 2:18:16 PM PST · by SJackson · 11 replies
    Commentary Magazine ^ | 11.07.2013 | Seth Mandel
    At times it seems like the sheer magnitude of bad news about ObamaCare can redound to its own benefit. It’s easy for individual pieces of bad news to get lost in the sea of failure that has characterized the Obama administration’s signature “achievement.” That might be the case with the most important story to appear about ObamaCare this week, from Tuesday’s edition of the New York Times. The paper reported that the Obama administration has ruled that the federal health-care program be exempted from the category of laws considered “federal health care programs.” Now, this is obviously dishonest: the federal...
  • Dirty medicine (Indian generic pharma fined $500m for fraudulent trials data)

    05/24/2013 4:21:02 AM PDT · by Zhang Fei · 2 replies
    Fortune ^ | May 15, 2013: 9:03 AM ET | Katherine Eban
    On the morning of Aug. 18, 2004, Dinesh Thakur hurried to a hastily arranged meeting with his boss at the gleaming offices of Ranbaxy Laboratories in Gurgaon, India, 20 miles south of New Delhi. (snip) His boss, Dr. Rajinder Kumar, Ranbaxy's head of research and development, had joined the generic-drug company just two months earlier from GlaxoSmithKline, where he had served as global head of psychiatry for clinical research and development. (snip) Like Kumar, Thakur had left a brand-name pharmaceutical company for Ranbaxy. Thakur, then 35, an American-trained engineer and a naturalized U.S. citizen, had worked at Bristol-Myers Squibb (BMY)...
  • Nationwide drug shortage problem increasing

    03/10/2012 10:46:01 AM PST · by aimhigh · 18 replies
    WNEM.com ^ | 03/10/2012 | CNN/WCBS
    A nationwide drug shortage that's dogging the food and drug administration is hitting home with first responders. For emergency medical technicians, shortages can mean the difference between life and death. Nationwide, anti-seizure drugs including intravenous Valium, Versed, and Ativan are among the dozens of drugs - including cancer treatments - that are in short supply.
  • THC, HMA, OREX, HCA, LNCR-Unusual Volume (h'care stocks +unusual pre-decision trades)Read more:

    06/29/2012 4:31:32 PM PDT · by STARWISE · 8 replies
    The Stock Market Watch ^ | 6-28-12 | Alex Fredericks
    We have found the following stocks had unusual volume spikes on Thursday, June 28, 2012. Tenet Healthcare Corp. (NYSE:THC) had a 86.9% volume spike trading 40,717,900 shares. THC’s 30-day average volume is 5,335,410. Shares closed at $5.25 +6.71%. Tenet Healthcare Corporation is an investor-owned health care services company whose subsidiaries and affiliates mainly operate acute care hospitals, ambulatory surgery centers, diagnostic imaging centers and related health care facilities. Health Management Associates (NYSE:HMA) had a 86.1% volume spike trading 24,950,900 shares. HMA’s 30-day average volume is 3,461,860. Shares closed at $7.49 +11.79%. Health Management Associates, Inc and its subsidiariesprovide health care...
  • Agenda 21 - What Is It? Apparently is is a plan to reduce the population

    06/22/2011 12:44:33 PM PDT · by TEXOKIE · 658 replies
    Vanity | Various
    Several people have become interested in a quite controversial topic called "AGENDA 21." They have requested being on a ping list for this topic. While I do not have time to do a thorough treatment of this subject, nor am I in any way an expert, I am willing at least for a time,to ping people as I run across articles which might pertain to this concern. It might be good to start with an examination of just what it is or might be. To kick this discussion and exploration off,I did a Google search (just for fun) on "Agenda...
  • Gingrich camp's 'last word' on Freddie Mac - Will not release records

    11/17/2011 11:58:43 AM PST · by Fred · 65 replies
    (CNN) - Former House Speaker Newt Gingrich will not release more Freddie Mac-related documents, according to campaign spokesman R.C. Hammond. Though the contender for the 2012 GOP presidential nomination said Wednesday that his campaign would "do what they can" to release more information about payments he received as a consultant from the government-backed mortgage group, Hammond backtracked later in the evening. When asked via email whether the campaign would release more Freddie Mac-related documents or if a fact sheet it released in the afternoon was the last word on the issue, Hammond responded to CNN, "last word."
  • Gingrich made big bucks pushing corporate welfare (BIG PHARMA)

    11/16/2011 6:54:03 PM PST · by Fred · 46 replies
    Washington Examiner ^ | 11/16/11 | Tom Carney
    Newt Gingrich spent the last decade being paid by big business to convince conservatives to support big-government policies that would profit his clients. Gingrich's consulting firm racked up $1.6 million in fees from the government-sponsored enterprise Freddie Mac, we learned this week from Bloomberg News. Gingrich's job was to help Freddie Mac win over conservatives to this market-distorting, bubble-fueling, housing-subsidy entity, which is now officially owned by the federal government. We also know that Growth Energy, an ethanol lobby, paid $312,500 to the Gingrich Group in 2009, according to the group's tax filing. Growth Energy lobbies to preserve many ethanol...
  • If you're sensitive to scorpion stings, you don't want to read this

    11/14/2011 6:15:36 PM PST · by BlazingArizona · 22 replies
    Arizona ^ | 11/14/11 | Ken Alltucker
    (Cannot quite due to copyright restrictions) Read here: http://www.a azcentral.com/news/articles/2011/11/10/20111110scorpion-drug-cost.html#ixzz1dje2uG1i
  • China and India Making Inroads in Biotech Drugs

    09/20/2011 1:17:35 AM PDT · by Cronos · 5 replies
    New York Times ^ | 18 Sep 2011 | Gardiner Harris
    Chinese and Indian drug makers have taken over much of the global trade in medicines and now manufacture more than 80 percent of the active ingredients in drugs sold worldwide. But they had never been able to copy the complex and expensive biotech medicines increasingly used to treat cancer, diabetes and other diseases in rich nations like the United States — until now. These generic drug companies say they are on the verge of selling cheaper copies of such huge sellers as Herceptin for breast cancer, Avastin for colon cancer, Rituxan for non-Hodgkin’s lymphoma and Enbrel for rheumatoid arthritis. Their...
  • Pfizer CEO Jeffrey Kindler Resigns Even Sooner Than We Predicted (Obamacare sellout)

    12/06/2010 9:14:15 AM PST · by jazusamo · 9 replies
    National Legal & Policy Center ^ | December 6, 2010 | Peter Flaherty
      Pfizer CEO Jeffrey Kindler has unexpectedly announced his resignation. NLPC recently filed a shareholder proposal with Pfizer critical of the company's deal with the White House to support ObamaCare. We foresaw Kindler's retirement in the resolution's supporting statement: If ObamaCare fails to control health care costs, as several studies now suggest, the government will seek savings through price controls. Shareholders ultimately will lose. Perhaps Kindler plans to retire before Pfizer is required to sell its products for less than the cost of production. We were more prescient than we realized.Kindler, who is only 55, cited the "extremely demanding"...